DE69841138D1 - Imidazolderivate als mdr-modulatoren - Google Patents
Imidazolderivate als mdr-modulatorenInfo
- Publication number
- DE69841138D1 DE69841138D1 DE69841138T DE69841138T DE69841138D1 DE 69841138 D1 DE69841138 D1 DE 69841138D1 DE 69841138 T DE69841138 T DE 69841138T DE 69841138 T DE69841138 T DE 69841138T DE 69841138 D1 DE69841138 D1 DE 69841138D1
- Authority
- DE
- Germany
- Prior art keywords
- imidazole derivatives
- mdr modulators
- mdr
- modulators
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89091197A | 1997-07-09 | 1997-07-09 | |
PCT/US1998/013926 WO1999002155A1 (en) | 1997-07-09 | 1998-07-06 | Imidazole derivatives as mdr modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69841138D1 true DE69841138D1 (de) | 2009-10-22 |
Family
ID=25397325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69841138T Expired - Lifetime DE69841138D1 (de) | 1997-07-09 | 1998-07-06 | Imidazolderivate als mdr-modulatoren |
Country Status (7)
Country | Link |
---|---|
US (1) | US5840721A (de) |
EP (2) | EP0999835B1 (de) |
JP (2) | JP4548868B2 (de) |
AU (1) | AU757558B2 (de) |
CA (1) | CA2295625C (de) |
DE (1) | DE69841138D1 (de) |
WO (1) | WO1999002155A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001026467A1 (en) | 1999-10-08 | 2001-04-19 | Ontogen Corporation | Methods of enhancing chemotherapy |
US20020147197A1 (en) * | 1999-10-08 | 2002-10-10 | Newman Michael J. | Methods and compositions for enhancing pharmaceutical treatments |
US6376514B1 (en) | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
WO2003007887A2 (en) * | 2001-07-20 | 2003-01-30 | Merck & Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
WO2003027096A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
CN101899006B (zh) | 2002-08-19 | 2013-11-06 | 劳洛斯治疗公司 | 2,4,5-三取代的咪唑及其作为抗菌剂的用途 |
JP2006518738A (ja) * | 2003-02-12 | 2006-08-17 | トランス テック ファーマ,インコーポレイテッド | 治療薬としての置換アゾール誘導体 |
FR2855520B1 (fr) * | 2003-05-27 | 2007-06-29 | Sod Conseils Rech Applic | Nouveaux derives d'imidazoles, leur preparation et leur utilisation en tant que medicament |
US7534805B2 (en) * | 2003-05-27 | 2009-05-19 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Imidazole derivatives, their preparation and their use as medicaments |
DK1692113T3 (en) | 2003-11-14 | 2018-01-08 | Lorus Therapeutics Inc | ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES |
EP1730118A1 (de) * | 2004-02-12 | 2006-12-13 | Transtech Pharma, Inc. | Substituierte azolderivate, zusammensetzungen und anwendungsverfahren |
CA2611032C (en) | 2005-05-25 | 2012-01-17 | Genesense Technologies Inc. | 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
US20070157355A1 (en) * | 2005-12-22 | 2007-07-12 | Katsin Daniel H | Engineered toweling |
EP1991544B1 (de) | 2006-01-30 | 2018-08-15 | vTv Therapeutics LLC | Substituierte imidazol- derivate und ihre verwendung als ptpase inhibitoren |
US20080090834A1 (en) * | 2006-07-06 | 2008-04-17 | Pfizer Inc | Selective azole pde10a inhibitor compounds |
JP2011505374A (ja) * | 2007-11-29 | 2011-02-24 | ザ・ホスピタル・フォー・シック・チルドレン | リソソーム障害を処置するための組成物および方法 |
MY164064A (en) * | 2010-10-13 | 2017-11-15 | Abbvie Bahamas Ltd | Anti-viral compounds |
EP2976342A4 (de) | 2013-03-20 | 2016-08-10 | Aptose Biosciences Inc | 2-substituierte imidazo[4,5-d]phenanthrolin-derivate und deren verwendung bei der behandlung von krebs |
CN103664931B (zh) * | 2013-07-20 | 2016-05-11 | 上饶师范学院 | 一种含苯并噻唑环和咪唑环希夫碱化合物及其制备方法 |
KR20160058960A (ko) | 2013-10-04 | 2016-05-25 | 압토스 바이오사이언시스 인코포레이티드 | 암을 치료하기 위한 조성물과 방법 |
RU2018101897A (ru) | 2015-06-22 | 2019-07-24 | Сумитомо Дайниппон Фарма Ко., Лтд. | Бициклическое гетероциклическое амидное производное |
WO2017146128A1 (ja) * | 2016-02-26 | 2017-08-31 | 大日本住友製薬株式会社 | イミダゾリルアミド誘導体 |
US11149047B2 (en) | 2017-10-30 | 2021-10-19 | Aptose Biosciences, Inc. | Aryl imidazoles for treatment of cancer |
WO2022249192A1 (en) * | 2021-05-27 | 2022-12-01 | Ramot At Tel-Aviv University Ltd. | Broad-spectrum metastasis suppressing compounds and therapeutic uses thereof in human tumors |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2801243A (en) * | 1956-06-05 | 1957-07-30 | American Home Prod | Imidazole salts of penicillin |
US3361755A (en) * | 1961-07-31 | 1968-01-02 | Air Prod & Chem | Substituted lophine compounds |
BE635804A (de) * | 1962-03-21 | |||
US3558645A (en) * | 1968-07-08 | 1971-01-26 | Sandoz Ag | 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids |
ZA717089B (en) * | 1970-11-16 | 1973-02-28 | Pfizer | Antiinflammatory imidazoles |
US3707475A (en) * | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4424229A (en) * | 1979-04-23 | 1984-01-03 | A/S Dumex (Dumex Ltd.) | Fluorine containing 2,4,5-triphenylimidazoles |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4348404A (en) * | 1980-07-21 | 1982-09-07 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-α-polyfluoroalkyl-1H-imidazole-2-methanamines |
DE3411997A1 (de) * | 1984-03-31 | 1985-10-17 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue redox-indikatoren |
US4632930A (en) * | 1984-11-30 | 1986-12-30 | E. I. Du Pont De Nemours And Company | Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives |
JPH0662871B2 (ja) * | 1985-01-29 | 1994-08-17 | 和光純薬工業株式会社 | 新規なイミダゾール誘導体 |
JPH0745477B2 (ja) * | 1985-04-03 | 1995-05-17 | 和光純薬工業株式会社 | イミダゾ−ル誘導体及びこれを発色成分として用いる測定法 |
JPS63208570A (ja) * | 1987-02-20 | 1988-08-30 | Hitachi Chem Co Ltd | 芳香族ジアミン及びその製造法 |
JPH01117867A (ja) * | 1987-10-30 | 1989-05-10 | Fujirebio Inc | イミダゾール誘導体 |
US4914096A (en) * | 1988-04-21 | 1990-04-03 | Sandoz Pharmaceuticals Corp. | 6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines |
DE3835195A1 (de) * | 1988-10-15 | 1990-04-19 | Basf Ag | Verfahren zur herstellung von p-nitrophenyl-imidazolen |
US5274095A (en) * | 1989-05-31 | 1993-12-28 | Boehringer Mannheim Gmbh | Diarylimidazoles |
US5312828A (en) * | 1989-06-14 | 1994-05-17 | Finkelstein Joseph A | Substituted imidazoles having angiotensin II receptor blocking activity |
JP3052364B2 (ja) * | 1989-12-19 | 2000-06-12 | 栗田工業株式会社 | ホスト化合物及び包接化合物 |
JP3084079B2 (ja) * | 1991-03-06 | 2000-09-04 | マナック株式会社 | ロフィン誘導体 |
US5210177A (en) * | 1991-05-31 | 1993-05-11 | Shell Oil Company | Polymerization of co/olefin with tetra ethyl diphosphine |
AU3592493A (en) * | 1992-01-13 | 1993-08-03 | Smithkline Beecham Corporation | Pyridyl substituted imidazoles |
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
EP0582164B1 (de) * | 1992-07-31 | 1998-12-23 | Bristol-Myers Squibb Company | Diphenyl Oxazole-, Thiazole- und Imidazole-Derivate als Inhibitoren der Wiederaufnahme des Adenosins |
US5296609A (en) * | 1993-04-09 | 1994-03-22 | Syntex Pharmaceuticals, Ltd. | Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives |
IL115582A0 (en) * | 1994-10-14 | 1996-01-19 | Lilly Co Eli | Methods for treating resistant tumors |
US5756527A (en) * | 1995-06-07 | 1998-05-26 | Ontogen Corporation | Imidazole derivatives useful as modulators of multi drug resistances |
US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
AU710897B2 (en) * | 1996-04-01 | 1999-09-30 | Rovi Solutions Corporation | A method for controlling copy protection in digital video networks |
EP0812829A1 (de) * | 1996-06-14 | 1997-12-17 | Ontogen Corporation | Substituierte Imidazole als Modulatoren für Mehrfachresistenz gegen Medikamente |
EP0812830A1 (de) * | 1996-06-14 | 1997-12-17 | Ontogen Corporation | Modulatoren von Mehrfachresistenz gegen Medikamente |
-
1997
- 1997-10-16 US US08/951,695 patent/US5840721A/en not_active Expired - Lifetime
-
1998
- 1998-07-06 DE DE69841138T patent/DE69841138D1/de not_active Expired - Lifetime
- 1998-07-06 JP JP50879799A patent/JP4548868B2/ja not_active Expired - Fee Related
- 1998-07-06 CA CA2295625A patent/CA2295625C/en not_active Expired - Fee Related
- 1998-07-06 EP EP98934267A patent/EP0999835B1/de not_active Expired - Lifetime
- 1998-07-06 EP EP09004628A patent/EP2082740A3/de not_active Withdrawn
- 1998-07-06 AU AU83832/98A patent/AU757558B2/en not_active Ceased
- 1998-07-06 WO PCT/US1998/013926 patent/WO1999002155A1/en active IP Right Grant
-
2009
- 2009-07-24 JP JP2009172624A patent/JP2009280601A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0999835B1 (de) | 2009-09-09 |
EP2082740A2 (de) | 2009-07-29 |
AU757558B2 (en) | 2003-02-27 |
US5840721A (en) | 1998-11-24 |
EP0999835A1 (de) | 2000-05-17 |
EP0999835A4 (de) | 2004-08-25 |
JP2002508007A (ja) | 2002-03-12 |
JP2009280601A (ja) | 2009-12-03 |
CA2295625C (en) | 2011-04-19 |
CA2295625A1 (en) | 1999-01-21 |
WO1999002155A1 (en) | 1999-01-21 |
AU8383298A (en) | 1999-02-08 |
JP4548868B2 (ja) | 2010-09-22 |
EP2082740A3 (de) | 2009-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69841138D1 (de) | Imidazolderivate als mdr-modulatoren | |
DE59511103D1 (de) | 1-h-3-aryl-pyrrolidin-2,4-dion-derivate als schädlingsbekämpfungsmittel | |
DE69712331D1 (de) | Pyrimidin-4-on derivate als pestizidesmittel | |
DE69930518D1 (de) | Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate | |
DE69718351D1 (de) | Diaminobenzoesäure derivate als farbstoffvorläufer | |
PT994890E (pt) | Derivados de benzimidazole | |
ATE277925T1 (de) | Pleuromutlin-derivate als antimikrobielles wirkungsmittel | |
PT1005446E (pt) | Derivados de n-aroilfenilalanina | |
ATE224366T1 (de) | D-prolinderivate | |
ATE290001T1 (de) | Neue substituierte imidazolverbindungen | |
DE69719344D1 (de) | 4-substituierte-3-(2-amino-2-cycloalkylmethyl)-acetamido-azetidin-2-on-derivate als cystein-proteinas-regulatoren | |
DE69806141D1 (de) | Indazoleamid-verbindungen als serotoninergene mittel | |
DE59813430D1 (de) | Perylenhydrazidimide als Carbonylderivatisierungsreagenzien | |
ATE255098T1 (de) | Substituierte chromanderivate | |
ATE221052T1 (de) | Tetrahydrochinolinderivate als eaa antagonisten | |
PT1003719E (pt) | Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida | |
PT1027362E (pt) | Derivados de cetolidos 2-halogeno-6-o-substituidos | |
ATE532769T1 (de) | 1-aryl-3-iminopyrazole als pestizide | |
DE60003072D1 (de) | Thiazolidindion-derivate als antidiabetika | |
NO982124D0 (no) | Kondenserte imidazolderivater som multilegemiddel resistanse modulatorer | |
ATE187165T1 (de) | Benzophenonhydrazon-derivate als insektizide | |
PT966437E (pt) | Derivados de 5-aroilnaftaleno | |
DE69806042D1 (de) | Phenylalkyl imidazole derivate als h3 rezeptor liganden | |
ATE292143T1 (de) | Angiotensinderivate | |
DE69527785D1 (de) | Chinuclidin-n-oxidderivate als muscarin rezeptor liganden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: TAIJI BIOMEDICAL, INC., PALO ALTO, CALIF., US |
|
8364 | No opposition during term of opposition |